Athera Biotechnologies' Grant

Athera Biotechnologies raised a round of funding on June 19, 2013. Investors include Seventh Framework Programme.

Athera Biotechnologies has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The lead product ca…

Articles about Athera Biotechnologies' Grant: